Discount Code (0% Off) has been applied.
 
Enter a search term.

If you can't find what you were looking for, please contact us using one of the methods below so we can better serve you.

1 (800) 854-7220
answers@mcguff.com Suggest an Item
Venofer® Iron Sucrose Injection 20 mg/mL, Single Dose Vial 5 mL, Each
Manufacturer: American Regent

Venofer® Iron Sucrose Injection 20 mg/mL, Single Dose Vial 5 mL, Each

Venofer is currently in irregular supply from our manufacturer. 

 

 

To prevent backorders, McGuff may purchase from approved suppliers rather than directly from the manufacturer. The price may vary accordingly.

 

$100.80
Item Code: 006247
Mfg Part #: 00517-2340-10
This product is only available to licensed healthcare professionals.
Select your shipping method. This is helpful to expedite a portion of your order.
To reduce overall packaging and shipping costs, our shipping department will pack your orders in as few boxes as possible. Compounded drugs must ship separately from our other products. When choosing Next Day or 2nd Day Air shipping methods, final shipping totals will be calculated when your order is packed and invoiced. Box size and package destination does not affect shipping fee calculations. The number of boxes is determined by size, weight and quantity of products ordered. For additional information or questions, please contact us.
  Usually ships within 24 hours.

Venofer (Iron Sucrose) Injection, USP is a sterile, aqueous iron replacement solution designed for intravenous use. It is primarily indicated for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD), including those undergoing hemodialysis, non-dialysis, or peritoneal dialysis.

 

Key Benefits:

  • Effective Iron Replacement: Supports iron levels in CKD patients with IDA, enhancing hemoglobin and hematocrit levels.
  • Intravenous Delivery: Provides an alternative for patients who cannot tolerate oral iron, ensuring adequate iron replacement.
  • Multiple Dosage Options: Available in varying concentrations suitable for both adult and pediatric patients.

 

Dosage and Administration:

Venofer must be administered intravenously and is tailored based on CKD patient type and age:

  • Adults:Pediatric Patients (2 Years and Older): 0.5 mg/kg IV, every 2 to 4 weeks, not exceeding 100 mg per dose.
    • Hemodialysis-Dependent CKD (HDD-CKD): 100 mg via slow IV injection per session.
    • Non-Dialysis Dependent CKD (NDD-CKD): 200 mg via slow IV injection or infusion, five doses over 14 days.
    • Peritoneal Dialysis Dependent CKD (PDD-CKD): 300 mg or 400 mg IV infusion in divided doses.

 

Why Choose Venofer Injection?

  • Supports Hemoglobin Levels: Clinically proven to improve hemoglobin in CKD-related iron deficiency anemia.
  • Trusted in Nephrology: Widely used in nephrology settings due to its efficacy in managing iron levels in dialysis patients.
  • Available in Convenient Single-Dose Vials: Concentrations of 50 mg/2.5 mL, 100 mg/5 mL, and 200 mg/10 mL (20 mg/mL) for tailored dosing.

 

Warnings:

  • Hypersensitivity Reactions: Serious hypersensitivity, including anaphylactic reactions, may occur. Monitor patients during and for 30 minutes post-administration.
  • Hypotension Risk: Venofer may cause hypotension. Administer slowly and monitor closely.
  • Avoid Iron Overload: Regular hematologic monitoring is essential to prevent iron overload.

 

Disclaimer:

This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.

Products specifications
Medical License Required Yes
Class Rx
Product Name Injection
Brand Name Venofer®
Generic Name Iron Sucrose Complex
Route of Administration Intravenous (IV)
Strength 20 mg/mL
Volume 5 mL
Container Single Dose Vial
Feature Preservative-Free
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68 to 77ºF)
Therapeutic Class Iron Supplement
Unit of Measure Each

Venofer (Iron Sucrose) Injection, USP is a sterile, aqueous iron replacement solution designed for intravenous use. It is primarily indicated for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD), including those undergoing hemodialysis, non-dialysis, or peritoneal dialysis.

 

Key Benefits:

  • Effective Iron Replacement: Supports iron levels in CKD patients with IDA, enhancing hemoglobin and hematocrit levels.
  • Intravenous Delivery: Provides an alternative for patients who cannot tolerate oral iron, ensuring adequate iron replacement.
  • Multiple Dosage Options: Available in varying concentrations suitable for both adult and pediatric patients.

 

Dosage and Administration:

Venofer must be administered intravenously and is tailored based on CKD patient type and age:

  • Adults:Pediatric Patients (2 Years and Older): 0.5 mg/kg IV, every 2 to 4 weeks, not exceeding 100 mg per dose.
    • Hemodialysis-Dependent CKD (HDD-CKD): 100 mg via slow IV injection per session.
    • Non-Dialysis Dependent CKD (NDD-CKD): 200 mg via slow IV injection or infusion, five doses over 14 days.
    • Peritoneal Dialysis Dependent CKD (PDD-CKD): 300 mg or 400 mg IV infusion in divided doses.

 

Why Choose Venofer Injection?

  • Supports Hemoglobin Levels: Clinically proven to improve hemoglobin in CKD-related iron deficiency anemia.
  • Trusted in Nephrology: Widely used in nephrology settings due to its efficacy in managing iron levels in dialysis patients.
  • Available in Convenient Single-Dose Vials: Concentrations of 50 mg/2.5 mL, 100 mg/5 mL, and 200 mg/10 mL (20 mg/mL) for tailored dosing.

 

Warnings:

  • Hypersensitivity Reactions: Serious hypersensitivity, including anaphylactic reactions, may occur. Monitor patients during and for 30 minutes post-administration.
  • Hypotension Risk: Venofer may cause hypotension. Administer slowly and monitor closely.
  • Avoid Iron Overload: Regular hematologic monitoring is essential to prevent iron overload.

 

Disclaimer:

This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.

Products specifications
Medical License Required Yes
Class Rx
Product Name Injection
Brand Name Venofer®
Generic Name Iron Sucrose Complex
Route of Administration Intravenous (IV)
Strength 20 mg/mL
Volume 5 mL
Container Single Dose Vial
Feature Preservative-Free
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68 to 77ºF)
Therapeutic Class Iron Supplement
Unit of Measure Each

Coronavirus (COVID-19)

Due to the Coronavirus (COVID-19) outbreak worldwide, the global demand for some Personal Protective Equipment (PPE) is exceeding current supply availability.

In addition, the manufacturing of the PPE and many other wound care/infection prevention products have been impacted by the global response to the Coronavirus. While you may see product availability reduction in the near-term, please be assured that we at McGuff Medical are continuing to work diligently to ensure an uninterrupted supply of products and alternative products to you.

Additionally, in order to ensure healthcare providers have access to the PPEs they need, the McGuff Company is temporarily limiting PPEs to healthcare providers.

As always, please feel free to reach out to our McGuff Customer Service team with any questions that you may have.

Click here for updates regarding Coronavirus Pandemic and Your Supplies and a message from our President